Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 2/20 | 0.39 |
| ▸ | ITGA5 | P08648 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.32 |
| ▸ | ASPH | Q12797 | 1/20 | 0.32 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.32 |
| ▸ | HIF1AN | Q9NWT6 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromoacetic Acid SCHEMBL1064789 | 0.81 | TSHR (0.48) | ALDH1A1SMN1; SMN2KMT2AMEN1PKM | |
| SCHEMBL21955962 | 0.80 | ITGB1 (0.37) | ITGB1ITGA5ALDH1A1EGLN1SMN1; SMN2 | |
| SCHEMBL2902587 | 0.79 | — | — | |
| SCHEMBL9689585 | 0.75 | TSHR (0.43) | ITGB1ITGA5ALDH1A1EGLN1KMT2A | |
| Glycine SCHEMBL9555848 | 0.71 | GLRA1 (0.46) | ITGB1ITGA5ALDH1A1EGLN1KMT2A | |
| SCHEMBL2760653 | 0.71 | RECQL (0.31) | — | |
| SCHEMBL2083155 | 0.71 | L3MBTL1 (0.40) | ALDH1A1KMT2AKDM4EMEN1MAPT | |
| Succinic Acid SCHEMBL28916613 | 0.71 | LMNA (0.45) | ALDH1A1EGLN1KMT2AKDM4EMEN1 | |
| Succinic Acid SCHEMBL722926 | 0.71 | LMNA (0.45) | ALDH1A1EGLN1KMT2AKDM4EMEN1 | |
| SCHEMBL6738514 | 0.71 | LMNA (0.39) | SMN1; SMN2BBOX1KMT2AMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112321443-A | Dextropropoxyphene artificial hapten as well as preparation method and application thereof | 广州万孚生物技术股份有限公司 | 2021-02-05 | — | — | CN | disclosed |
| WO-2014053603-A1 | MORPHINE-6-GLUCURONIDE DERIVATIVES, IMMUNOGENS AND IMMUNOASSAY | CISBIO BIOASSAYS (FR) | 2014-04-10 | — | — | WO | disclosed |
| EP-1321466-B1 | Haptens, immunogens, antibodies and conjugates for 2-oxo-3-hydroxy LSD | RANDOX LAB LTD (GB) | 2011-01-26 | — | — | EP | disclosed |
| EP-1333023-B1 | Immunogens, antibodies and conjugates to ketamine and its metabolites | RANDOX LAB LTD (GB) | 2010-12-22 | — | — | EP | disclosed |
| EP-1323718-B1 | Haptens, immunogens and antibodies to oxycodone and its metabolites | RANDOX LAB LTD (GB) | 2010-08-25 | — | — | EP | disclosed |
| EP-1732880-B1 | ASSAYS FOR AMPHETAMINE AND METHAMPHETAMINE | SIEMENS HEALTHCARE DIAGNOSTICS (US) | 2010-08-18 | — | — | EP | disclosed |
| US-20090280499-A1 | METHOD AND KIT FOR DETECTING, OR DETERMINING 3,4- METHYLENEDIOXYMETHAMPHETAMINE | RANDOX LABORATORIES LIMITED (GB) | 2009-11-12 | — | — | US | disclosed |
| EP-1321772-B1 | Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine | RANDOX LAB LTD (GB) | 2008-09-17 | — | — | EP | disclosed |
| EP-1732880-A4 | ASSAYS FOR AMPHETAMINE AND METHAMPHETAMINE | DADE BEHRING INC (US) | 2008-05-14 | — | — | EP | disclosed |
| US-7371829-B2 | Haptens, immunogens, antibodies and conjugates to ketamine and its metabolites | RANDOX LABORATORIES LIMITED (GB) | 2008-05-13 | — | — | US | disclosed |
| US-20040121400-A1 | Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine | NORTHERN BANK LIMITED (IE) | 2004-06-24 | — | — | US | disclosed |
| US-20030224447-A1 | Haptens, immunogens, antibodies and conjugates to ketamine and its metabolites | RANDOX LABORATORIES LIMITED | 2003-12-04 | — | — | US | disclosed |
| US-20030170728-A1 | Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs | RANDOX LABORATORIES LIMITED | 2003-09-11 | — | — | US | disclosed |
| US-20030157565-A1 | Haptens, immunogens and antibodies to oxycodone and its metabolites | RANDOX LABORATORIES LTD. (IE) | 2003-08-21 | — | — | US | disclosed |
| EP-1333023-A1 | Haptens, immunogens, antibodies and conjugates to ketamine and its metabolites | Randox Laboratories Ltd. (GB) | 2003-08-06 | — | — | EP | disclosed |
| US-20030143655-A1 | Haptens, immunogens, antibodies and conjugates to 2-oxo-3-hydroxy-LSD | NORTHERN BANK LIMITED (IE) | 2003-07-31 | — | — | US | disclosed |
| EP-1323718-A2 | Haptens, immunogens and antibodies to oxycodone and its metabolites | Randox Laboratories Ltd. (GB) | 2003-07-02 | — | — | EP | disclosed |
| EP-1321466-A1 | Haptens, immunogens, antibodies and conjugates for 2-oxo-3-hydroxy LSD | Randox Laboratories Ltd. (GB) | 2003-06-25 | — | — | EP | disclosed |
| EP-1321772-A1 | Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine | Randox Laboratories Ltd. (GB) | 2003-06-25 | — | — | EP | disclosed |
| EP-1312923-A2 | Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs | Randox Laboratories Ltd. (GB) | 2003-05-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040121400-A1 | Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine | KIT, PNMT, HNMT | ITGB1 3731/4885ITGA5 2304/4885ALDH1A1 1340/4885 |
| US-20090280499-A1 | METHOD AND KIT FOR DETECTING, OR DETERMINING 3,4- METHYLENEDIOXYMETHAMPHETAMINE | KIT, PNMT, HNMT | ITGB1 3733/4885ITGA5 1881/4885ALDH1A1 1525/4885 |
| US-20030170728-A1 | Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs | OPRK1, KIT, OPRM1 | ITGB1 2858/4885ITGA5 749/4885ALDH1A1 1151/4885 |
| US-20030157565-A1 | Haptens, immunogens and antibodies to oxycodone and its metabolites | OPRK1, OPRD1, OPRM1 | ITGB1 1424/4885ITGA5 1609/4885ALDH1A1 473/4885 |
| US-20030143655-A1 | Haptens, immunogens, antibodies and conjugates to 2-oxo-3-hydroxy-LSD | HNMT, HRH4, HRH3 | ITGB1 4550/4885ITGA5 3375/4885ALDH1A1 2079/4885 |
| US-20030224447-A1 | Haptens, immunogens, antibodies and conjugates to ketamine and its metabolites | HNMT, HLA-DRB1, HLA-A | ITGB1 2601/4885ITGA5 1989/4885ALDH1A1 659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.